Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium
In an era of increasing use of immunomodulator (IM) therapy, opportunistic infections have emerged as a pivotal safety issue in patients with inflammatory bowel disease (IBD). Today's challenge to the physician is not only to manage IBD, but also to recognise, prevent and treat common and uncommon infections. The recent European ECCO guidelines on the management and prevention of opportunistic infections in patients with IBD provide clinicians with guidance on the prevention, detection and management of opportunistic infections in patients with IBD. Proposals may appear radical, potentially changing current practice, but we believe that the recommendations will help optimise patient outcomes by reducing morbidity and mortality related to opportunistic infections in patients with IBD. In this ongoing process, prevention is far the first and most important step. Prevention of opportunistic infections relies on recognition of risk factors for infection, the use of primary or secondary chemoprophylaxis, careful monitoring (clinical and laboratory work-up) before and during the use of immunomodulators, vaccination and education of the patient. Special recommendations should also be given to patients before travel. Additionally, this paper discusses how the ECCO guidelines can be implemented in Belgium according to reimbursement legislation.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2010 |
|---|---|
| Erschienen: |
2010 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
Acta gastro-enterologica Belgica - 73(2010), 1 vom: 06. Jan., Seite 41-5 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rahier, J F [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 22.07.2010 Date Revised 23.09.2016 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM197980767 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM197980767 | ||
| 003 | DE-627 | ||
| 005 | 20231223211740.0 | ||
| 007 | tu | ||
| 008 | 231223s2010 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0660.xml |
| 035 | |a (DE-627)NLM197980767 | ||
| 035 | |a (NLM)20458849 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rahier, J F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium |
| 264 | 1 | |c 2010 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 22.07.2010 | ||
| 500 | |a Date Revised 23.09.2016 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a In an era of increasing use of immunomodulator (IM) therapy, opportunistic infections have emerged as a pivotal safety issue in patients with inflammatory bowel disease (IBD). Today's challenge to the physician is not only to manage IBD, but also to recognise, prevent and treat common and uncommon infections. The recent European ECCO guidelines on the management and prevention of opportunistic infections in patients with IBD provide clinicians with guidance on the prevention, detection and management of opportunistic infections in patients with IBD. Proposals may appear radical, potentially changing current practice, but we believe that the recommendations will help optimise patient outcomes by reducing morbidity and mortality related to opportunistic infections in patients with IBD. In this ongoing process, prevention is far the first and most important step. Prevention of opportunistic infections relies on recognition of risk factors for infection, the use of primary or secondary chemoprophylaxis, careful monitoring (clinical and laboratory work-up) before and during the use of immunomodulators, vaccination and education of the patient. Special recommendations should also be given to patients before travel. Additionally, this paper discusses how the ECCO guidelines can be implemented in Belgium according to reimbursement legislation | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Moreels, T |e verfasserin |4 aut | |
| 700 | 1 | |a De Munter, P |e verfasserin |4 aut | |
| 700 | 1 | |a D'Haens, G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta gastro-enterologica Belgica |d 1946 |g 73(2010), 1 vom: 06. Jan., Seite 41-5 |w (DE-627)NLM000123749 |x 1784-3227 |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2010 |g number:1 |g day:06 |g month:01 |g pages:41-5 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2010 |e 1 |b 06 |c 01 |h 41-5 | ||